electroCore, Inc. Announces Agreement with Pro Medical Baltic to be Exclusive Distributor for gammaCore Sapphire™ in Eastern Europe

Rhea-AI Summary

electroCore, Inc. (Nasdaq: ECOR) has partnered with Pro Medical Baltic UAB to exclusively distribute its gammaCore Sapphire™ non-invasive vagus nerve stimulation (nVNS) therapy for headache disorders in Eastern Europe, including Lithuania, Latvia, Belarus, Kazakhstan, and Ukraine. The three-year agreement aims to enhance market access for gammaCore's treatment of cluster headaches and migraines. Pro Medical Baltic has experience in neuromodulation and a robust network of physicians, which is expected to benefit the introduction of nVNS therapy in the region.

Positive

• Partnership with Pro Medical Baltic for exclusive distribution boosts market presence in Eastern Europe.
• Pro Medical Baltic's experience in neuromodulation enhances credibility for gammaCore therapy.
• The agreement aims to treat cluster headache and refractory migraine, expanding patient access.

Negative

• None.

ROCKAWAY, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has entered into an agreement with Pro Medical Baltic UAB (“PMB”), whereby PMB will serve as the exclusive distributor of gammaCore Sapphire™ non-invasive vagus nerve stimulation (“nVNS”) to patients suffering from primary headache disorders in Lithuania, Latvia, Belarus, Kazakhstan and Ukraine.

“We are delighted to partner with Pro Medical Baltic to be able to introduce our nVNS therapy to new patients in Eastern Europe,” said Iain Strickland, electroCore’s Vice President of European Operations. “Pro Medical Baltic already has experience working with neuromodulation products, and we look forward to supporting their market access activities for gammaCore. This agreement is hopefully the first of many that will see electroCore, Inc. expand into new markets.”

Pro Medical Baltic has been operating in these countries for five years and has an established network of leading physicians familiar with the benefits of neuromodulation. PMB currently distributes neuromodulation devices such as implantable vagus nerve stimulators and will focus on distributing gammaCore for treatment of cluster headache and refractory migraine. The initial term of the agreement is three years, and the agreement contains customary terms and conditions, such as minimum purchase commitments.

About Pro Medical Baltic
Pro Medical Baltic is a wholesale medical supplier of a wide range of medical devices and medical equipment for hospitals and healthcare centers. Pro Medical Baltic is committed to introducing and promoting the newest methods of treatment for neurological conditions using neuromodulation devices.

For more information, visit http://www.pmbaltic.eu/

About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

About gammaCore™

gammaCore™ (nVNS) is the first non-invasive, hand-held medical therapy applied at the neck as an adjunctive therapy to treat migraine and cluster headache through the utilization of a mild electrical stimulation to the vagus nerve that passes through the skin. Designed as a portable, easy-to-use technology, gammaCore can be self-administered by patients, as needed, without the potential side effects associated with commonly prescribed drugs. When placed on a patient’s neck over the vagus nerve, gammaCore stimulates the nerve’s afferent fibers, which may lead to a reduction of pain in patients. 

gammaCore is FDA cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster hea

FAQ

What is the significance of electroCore's partnership with Pro Medical Baltic?

The partnership allows electroCore to expand its market presence in Eastern Europe by distributing gammaCore Sapphire™ for headache therapies.

Which countries are included in electroCore's distribution agreement?

The distribution agreement includes Lithuania, Latvia, Belarus, Kazakhstan, and Ukraine.

What is gammaCore Sapphire™ used for?

gammaCore Sapphire™ is used for non-invasive vagus nerve stimulation to treat cluster headaches and migraines.

How long is the distribution agreement between electroCore and Pro Medical Baltic?

The initial term of the agreement is three years.

What kind of experience does Pro Medical Baltic have in the medical field?

Pro Medical Baltic has five years of experience working with neuromodulation products and has established relationships with leading physicians.